HomeProductsImprintTermsContactLinksHelp 
Products > Hemoglobin controls > Hemoglobin Erythro -6-Dehydrogenase: Glucose-6-Phosphate Dehydrogenase Controls
Zertifikat
Hemoglobin, Erythro-6-Dehydrogenase: Glucose-6-Phosphate Dehydrogenase Controls, Normal, Intermediate and Depressed


BGT’s Hemoglobin based G-6-PDH Control is useful in tests designed to detect G-6-PDH deficiencies and in the management of drug sensitivities related to this deficiency. The controls, normal, intermediate and depressed, consist of stabilized oxyhemoglobin bases and adjusted levels of G-6-PDH. All three controls perform remarkably well in kinetic, visual or fluorescent procedures. Stability is at least 5 days reconstituted, 21 days frozen after reconstitution and two years as a lyophilized powder. The bulk product is available to OEM customers (minimum quantity: 1 liter) to be dispensed and lyophilized in house.

 

  • HB-108 6X0.5 ml Normal Controls (DIMDI Reg.-Nr.: DE/CA22/1116-211-IVD)
  • HB-108IN 6X0.5 ml Intermediate Controls (DIMDI Reg.-Nr.: DE/CA22/1116-216-IVD)
  • HB-108DE 6X0.5 ml Depressed Controls (DIMDI Reg.-Nr.: DE/CA22/1116-215-IVD)


 img/seiten/Tabelle-unten1.jpg

img/seiten/ce-zeichen.gif
Manufacturer:

img/bgt-logo-neu.gif
Von-Langen-Weg 10
D-48565 Steinfurt
Tel.: 02551/4090  Fax.: 02551/1298
Web:
www.biogentechnologies.com

© 2007-2012 by BGT BioGenTechnologies GmbH - BGT Biogentechnnologies